PsychiatryNews.net

Psychiatry Xagena

Search results for "Nicotine"

Easy access to cessation medication for diverse populations could help many more smokers to stop. Tobacco kills around 5 million people worldwide every year and is the leading preventable cause of ...


Subjects with problem gambling behavior have personality profiles similar to the profiles of those with alcohol, marijuana and nicotine-associated addictive disorders. It has been difficult to iden ...


Epidemiologic Survey of Alcohol and Related Conditions ( NESARC ) has showed for the first time that middle age and Native American race increase the likelihood of current or lifetime major depressive ...


Research on the genetics of smoking has focused on genes that are thought to be related to nicotine metabolism, personality traits, and regulation of emotions. According to a genetic study, publishe ...


The poor safety profile of the smoking-cessation drug Varenicline ( Chantix, Champix ) makes it unsuitable for first-line use, according to a study published in the journal PLoS One,Varenicline, which ...


In 2009, the FDA ( Food and Drug Administration ) issued a black box warning for Varenicline ( Champix; in Europe: Champix ) regarding neuropsychiatric events. Researchers used data from randomized c ...


Placebo-controlled trials indicate that Cytisine, a partial agonist that binds the nicotinic acetylcholine receptor and is used for smoking cessation, almost doubles the chances of quitting at 6 month ...